BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 11465075)

  • 21. Learning the ABC of oral fungal drug resistance.
    Cannon RD; Holmes AR
    Mol Oral Microbiol; 2015 Dec; 30(6):425-37. PubMed ID: 26042641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candida Efflux ATPases and Antiporters in Clinical Drug Resistance.
    Prasad R; Rawal MK; Shah AH
    Adv Exp Med Biol; 2016; 892():351-376. PubMed ID: 26721282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular basis of resistance to azole antifungals.
    Lupetti A; Danesi R; Campa M; Del Tacca M; Kelly S
    Trends Mol Med; 2002 Feb; 8(2):76-81. PubMed ID: 11815273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of multidrug resistance in pathogenic fungi.
    Morschhäuser J
    Fungal Genet Biol; 2010 Feb; 47(2):94-106. PubMed ID: 19665571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug transporters of Candida species in clinical azole resistance.
    Prasad R; Nair R; Banerjee A
    Fungal Genet Biol; 2019 Nov; 132():103252. PubMed ID: 31302289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and functional characterization of
    Utami ST; Indriani CI; Bowolaksono A; Yaguchi T; Chen X; Niimi K; Niimi M; Kajiwara S
    Biosci Biotechnol Biochem; 2020 Jul; 84(7):1373-1383. PubMed ID: 32163007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carrier-Mediated Drug Uptake in Fungal Pathogens.
    Galocha M; Costa IV; Teixeira MC
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33182427
    [No Abstract]   [Full Text] [Related]  

  • 28. Multifactorial Mechanisms of Tolerance to Ketoconazole in Candida albicans.
    Xu Y; Lu H; Zhu S; Li WQ; Jiang YY; Berman J; Yang F
    Microbiol Spectr; 2021 Sep; 9(1):e0032121. PubMed ID: 34160280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression.
    Pinjon E; Jackson CJ; Kelly SL; Sanglard D; Moran G; Coleman DC; Sullivan DJ
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1312-8. PubMed ID: 15793103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Combination Fluorescence Assay Demonstrates Increased Efflux Pump Activity as a Resistance Mechanism in Azole-Resistant Vaginal Candida albicans Isolates.
    Bhattacharya S; Sobel JD; White TC
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5858-66. PubMed ID: 27431223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Azole resistance in Candida albicans].
    Perea S
    Rev Esp Quimioter; 2000 Sep; 13(3):314-7. PubMed ID: 11086283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Aspergillus fumigatus multidrug transporter genes and their potential involvement in antifungal resistance.
    Meneau I; Coste AT; Sanglard D
    Med Mycol; 2016 Aug; 54(6):616-27. PubMed ID: 26933209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting efflux pumps to overcome antifungal drug resistance.
    Holmes AR; Cardno TS; Strouse JJ; Ivnitski-Steele I; Keniya MV; Lackovic K; Monk BC; Sklar LA; Cannon RD
    Future Med Chem; 2016 Aug; 8(12):1485-501. PubMed ID: 27463566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug resistance in yeasts--an emerging scenario.
    Prasad R; Panwar SL; Smriti
    Adv Microb Physiol; 2002; 46():155-201. PubMed ID: 12073653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on antifungal resistance in Aspergillus and Candida.
    Arendrup MC
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():42-8. PubMed ID: 24372701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains.
    Maesaki S; Marichal P; Hossain MA; Sanglard D; Vanden Bossche H; Kohno S
    J Antimicrob Chemother; 1998 Dec; 42(6):747-53. PubMed ID: 10052898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel Zn2-Cys6 Transcription Factor AtrR Plays a Key Role in an Azole Resistance Mechanism of Aspergillus fumigatus by Co-regulating cyp51A and cdr1B Expressions.
    Hagiwara D; Miura D; Shimizu K; Paul S; Ohba A; Gonoi T; Watanabe A; Kamei K; Shintani T; Moye-Rowley WS; Kawamoto S; Gomi K
    PLoS Pathog; 2017 Jan; 13(1):e1006096. PubMed ID: 28052140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yeast ATP-binding cassette transporters conferring multidrug resistance.
    Prasad R; Goffeau A
    Annu Rev Microbiol; 2012; 66():39-63. PubMed ID: 22703054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes.
    MacPherson S; Akache B; Weber S; De Deken X; Raymond M; Turcotte B
    Antimicrob Agents Chemother; 2005 May; 49(5):1745-52. PubMed ID: 15855491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.